Andrew B. JacobsSpecial Counsel

Headshot image for Andrew B. Jacobs



Andrew Jacobs advises leading investments banks, commercial banks, private equity and hedge funds and public and private companies in a wide range of transactions related to corporate finance and mergers and acquisitions. His practice focuses primarily on leveraged finance, where he represents borrowers and lenders on secured and unsecured debt offerings, syndicated loan transactions and out-of-court debt restructurings. Andrew also advises clients on initial public offerings and other equity offerings and regularly counsels public and private companies on mergers and acquisitions, corporate governance and compliance matters.

Representative Matters

Some of Andrew’s recent transactions include representing:
  • Bank of America as administrative agent and lead arranger and SunTrust Robinson Humphrey, MUFG Union Bank and Citizens Bank as arrangers in connection with a $2.125 billion credit facility, the proceeds of which were used in connection with WEX’s acquisition of Electronic Funds Source LLC, refinancing of indebtedness as well as for general corporate purposes.
  • Credit Suisse and J.P. Morgan as global financing coordinators, the joint-bookrunning managers and the other initial purchasers in connection with the Rule 144A offering of $20 billion aggregate principal amount of senior secured notes (reported as the fourth-largest corporate bond offering ever completed) and the Rule 144A offering of $3.25 billion aggregate principal amount of senior unsecured notes, in each case by subsidiaries of Dell, Inc. The proceeds were used (following release from escrow), together with cash on hand, to complete the acquisition of EMC Corporation by Dell Inc.
  • J.P. Morgan, Macquarie, Capital One Securities, KeyBanc Capital Markets, SunTrust Robinson Humphrey, and US Bancorp as joint book-running managers in connection with the Rule 144A offering of $375 million aggregate principal amount of 6% Senior Notes due 2025 by Eagle II Acquisition Company LLC, to be assumed by Eldorado Resorts, Inc. Proceeds from the facility were used in connection with Eldorado’s acquisition of Isle of Capri Casinos.
  • BofA Merrill Lynch and Scotiabank as joint book-running managers and ING, Société Générale, SEB, BMO Capital Markets, and GMP Securities as co-managers in connection with the Rule 144A offering of $1 billion aggregate principal amount of senior secured notes, comprised of $550 million aggregate principal amount of 7.5% Senior Secured Notes due 2020 and $450 million aggregate principal amount of 7.875% Senior Secured Notes due 2022 by Lundin Mining Corporation, a diversified base metals mining company. Proceeds were used, in part, to fund Lundin’s acquisition of 80% of the equity interests in the Candelaria mine and Ojos del Salado mine in Chile.
  • BofA Merrill Lynch, Citi and J.P. Morgan as dealer managers in exchange and cash tender offers by Range Resources Corporation to purchase or exchange certain of Memorial Resources Development Corp.'s and Range Resources Corporation's outstanding notes.  The transaction included four series of outstanding notes issued by Memorial and Range. The offers were executed in connection with the merger of Range Resources Corporation and Memorial Resources Development Corp.
  • NBCUniversal in its agreement, valued at $7.75 billion, with the International Olympic Committee to extend the exclusive U.S. broadcast rights for the Olympic Games through 2032.
  • Citi, BofA Merrill Lynch, Barclays, Deutsche Bank and UBS as underwriters in connection with the initial public offering of common shares of Fortress Transportation and Infrastructure LLC, representing limited liability company interests, resulting in gross proceeds of $340 million.
  • BofA Merrill Lynch, Citi and J.P. Morgan as underwriters in connection with the $4.35 billion initial public offering of hospital-operator HCA Holdings, Inc., which was the largest private equity-backed IPO in U.S. history.
  • HealthCare Royalty Partners in its acquisition of a portion of the royalty rights of Aviragen Therapeutics, Inc. related to a drug used in the treatment and prevention of flu in Asia.
  • Coca-Cola Enterprises Inc. in the restructuring of its business, including the sale, valued at approximately $12.3 billion, of its North American business to The Coca-Cola Company, the spin-off of its European business and the concurrent $822 million purchase of The Coca-Cola Company’s Norway and Sweden bottling operations.

Admitted To Practice

New York


J.D., St. John' s University School of Law, 2009; Member, St. John’s Law Review

B.A., Boston College, 2003